The hotspot variation c.649dupC (p.R217Pfs*8), identified in six cases, further supports its role as a diagnostic marker for BFIE, with prior studies reporting this variant in 50%–70% of PRRT2-related epilepsy cases globally (Steinlein et al., 2012). The gene discussed is PRRT2; the disease is epilepsy.